The Europe implantable ports market is expected to reach USD 400,809.69 thousand by 2030 from USD 198,522.29 thousand in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2030.
Market Segmentation
Europe Implantable Ports Market, By Type (Single Lumen, Double Lumen, and Power-Injectable), Material (Polyurethane, Silicone, Titanium, and Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, and Others), End Users (Hospitals, Clinics, Ambulatory Surgical Centre, Dialysis Centers, and Others), Country (Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, and Rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Implantable Ports Market Dynamics
Drivers
• Increasing prevalence of chronic diseases
• Growing demand for minimally invasive procedures
Restraint
• Risk of infections and mechanical complications
Opportunity
• Rising demand for implantable port devices due to high success rate
Market Players
Some of the major market players operating in the Europe implantable ports market are:
• B. Braun SE
• AngioDynamics
• BD
• Teleflex Incorporated
• Vygon
• ICU Medical, Inc.
• AMI GmbH
• PakuMedmedical products gmbh
TABLE OF CONTENT
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 OVERVIEW OF THE EUROPE IMPLANTABLE PORTS MARKET 13
1.4 CURRENCY AND PRICING 14
1.5 LIMITATIONS 14
1.6 MARKETS COVERED 14
2 MARKET SEGMENTATION 16
2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 MULTIVARIATE MODELLING 23
2.7 TYPE SEGMENT LIFELINE CURVE 23
2.8 MARKET END USERS COVERAGE GRID 24
2.9 Cognate Lifesciences MARKET POSITION GRID 25
2.10 VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 30
4.1 CONSUMER BUYING BEHAVIOUR 31
4.2 FACTORS AFFECTING BUYING DECISION 31
4.3 PRODUCT ADOPTION SCENARIO 31
4.4 REGULATION COVERAGE 32
4.5 BRAND ANALYSIS 34
4.6 RAW MATERIAL SOURCING ANALYSIS 35
4.7 IMPORT EXPORT SCENARIO 35
4.8 PORTER'S 5 FORCES 37
5 SUPPLY CHAIN ANALYSIS 38
5.1 LOGISTIC COSTS SCENARIO 38
5.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 38
6 MARKET OVERVIEW 40
6.1 DRIVERS 42
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 42
6.1.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 42
6.1.3 INCREASING ONCOLOGY AND CHEMOTHERAPY PROCEDURES 43
6.1.4 IMPROVED DEVICE DESIGN AND FUNCTIONALITY 43
6.2 RESTRAINTS 44
6.2.1 RISK OF INFECTIONS AND MECHANICAL COMPLICATIONS 44
6.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL PROCESS 44
6.3 OPPORTUNITIES 45
6.3.1 RISING DEMAND FOR IMPLANTABLE PORT DEVICES DUE TO HIGH SUCCESS RATE 45
6.3.2 EXPANSION OF HOME-BASED HEALTHCARE 45
6.4 CHALLENGES 46
6.4.1 LACK OF SKILLED PROFESSIONALS OR EXPERTISE 46
6.4.2 PRODUCT RECALL OF IMPLANTABLE PORT DEVICES 46
7 EUROPE IMPLANTABLE PORTS MARKET, BY TYPE 48
7.1 OVERVIEW 49
7.2 SINGLE LUMEN 52
7.3 DOUBLE LUMEN 52
7.4 POWER- INJECTABLE 53
8 EUROPE IMPLANTABLE PORTS MARKET, BY MATERIAL 54
8.1 OVERVIEW 55
8.2 POLYURETHANE 58
8.3 SILICONE 58
8.4 TITANIUM 59
8.5 OTHERS 60
9 EUROPE IMPLANTABLE PORTS MARKET, BY APPLICATION 61
9.1 OVERVIEW 62
9.2 CHEMOTHERAPY 65
9.3 BLOOD TRANSFUSION 65
9.4 ANTIBIOTICS 66
9.5 INTRAVENOUS INFUSION OF BLOOD PRODUCT 67
9.6 PAIN MANAGEMENT 67
9.7 OTHERS 68
10 EUROPE IMPLANTABLE PORTS MARKET, BY END USERS 69
10.1 OVERVIEW 70
10.2 HOSPITALS 73
10.3 CLINICS 73
10.4 AMBULATORY SURGICAL CENTER 74
10.5 DIALYSIS CENTER 74
10.6 OTHERS 76
11 EUROPE IMPLANTABLE PORTS MARKET, BY REGION 77
11.1 EUROPE 78
11.1.1 GERMANY 84
11.1.2 U.K. 86
11.1.3 FRANCE 88
11.1.4 ITALY 90
11.1.5 RUSSIA 92
11.1.6 SPAIN 94
11.1.7 NETHERLANDS 96
11.1.8 SWITZERLAND 98
11.1.9 BELGIUM 100
11.1.10 TURKEY 102
11.1.11 REST OF EUROPE 104
12 EUROPE IMPLANTABLE PORTS MARKET: COMPANY LANDSCAPE 105
12.1 COMPANY SHARE ANALYSIS: EUROPE 105
13 SWOT 106
14 EUROPE IMPLANTABLE PORTS MARKET, COMPANY PROFILE 107
14.1 B.BRAUN SE 107
14.1.1 COMPANY SNAPSHOT 107
14.1.2 COMPANY SHARE ANALYSIS 107
14.1.3 PRODUCT PORTFOLIO 108
14.1.4 RECENT DEVELOPMENTS 108
14.2 ANGIODYNAMICS 109
14.2.1 COMPANY SNAPSHOT 109
14.2.2 REVENUE ANALYSIS 109
14.2.3 COMPANY SHARE ANALYSIS 110
14.2.4 PRODUCT PORTFOLIO 110
14.2.5 RECENT DEVELOPMENT 110
14.3 BD 111
14.3.1 COMPANY SNAPSHOT 111
14.3.2 REVENUE ANALYSIS 111
14.3.3 COMPANY SHARE ANALYSIS 112
14.3.4 PRODUCT PORTFOLIO 112
14.3.5 RECENT DEVELOPMENT 112
14.4 TELEFLEX INCORPORATED 113
14.4.1 COMPANY SNAPSHOT 113
14.4.2 REVENUE ANALYSIS 113
14.4.3 COMPANY SHARE ANALYSIS 114
14.4.4 PRODUCT PORTFOLIO 114
14.4.5 RECENT DEVELOPMENTS 114
14.5 VYGON 115
14.5.1 COMPANY SNAPSHOT 115
14.5.2 COMPANY SHARE ANALYSIS 115
14.5.3 PRODUCT PORTFOLIO 116
14.5.4 RECENT DEVELOPMENT 116
14.6 AMI GMBH 117
14.6.1 COMPANY SNAPSHOT 117
14.6.2 PRODUCT PORTFOLIO 117
14.6.3 RECENT DEVELOPMENT 117
14.7 DISTRICLASS MÉDICAL 118
14.7.1 COMPANY SNAPSHOT 118
14.7.2 PRODUCT PORTFOLIO 118
14.7.3 RECENT DEVELOPMENT 118
14.8 ICU MEDICAL, INC. 119
14.8.1 COMPANY SNAPSHOT 119
14.8.2 REVENUE ANALYSIS 119
14.8.3 PRODUCT PORTFOLIO 120
14.8.4 RECENT DEVELOPMENT 120
14.9 PAKUMEDMEDICAL PRODUCTS GMBH 121
14.9.1 COMPANY SNAPSHOT 121
14.9.2 PRODUCT PORTFOLIO 121
14.9.3 RECENT DEVELOPMENTS 121
15 QUESTIONNAIRE 122
16 RELATED REPORTS 125
Segmentation
Short Description
Europe Implantable Ports Market, By Type (Single Lumen, Double Lumen, and Power-Injectable), Material (Polyurethane, Silicone, Titanium, and Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, and Others), End Users (Hospitals, Clinics, Ambulatory Surgical Centre, Dialysis Centers, and Others), Country (Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, and Rest of Europe) - Industry Trends and Forecast to 2030
Market Definition
The Europe implantable ports market is the worldwide market for medical devices known as implantable ports. These devices are used in healthcare settings to facilitate repeated access to a patient's bloodstream to deliver medications, fluids, or blood products and for blood sampling. Implantable ports consist of two main components: a reservoir or chamber that is surgically implanted beneath the skin, usually in the chest or upper arm, and a catheter that connects the reservoir to a large vein, typically the subclavian vein or jugular vein. The catheter remains inside the patient's body, providing a stable access point for medical professionals to administer treatments or perform diagnostic procedures.
Market Segmentation
The Europe implantable ports market is segmented into four notable segments based on type, material, application, and end users.
• On the basis of type, the market is segmented into single lumen, double lumen, and power-injectable
• On the basis of material, the market is segmented into polyurethane, silicone, titanium, and others
• On the basis of application, the market is segmented into chemotherapy, blood transfusion, antibiotics, intravenous infusion of blood product, pain management, and others
• On the basis of end users, the market is segmented into hospitals, clinics, ambulatory surgical center, dialysis centers, and others
Market Players
Some of the major market players operating in the Europe implantable ports market are:
• B. Braun SE
• AngioDynamics
• BD
• Teleflex Incorporated
• Vygon
• ICU Medical, Inc.
• Districlass Médical
• AMI GmbH
• PakuMedmedical products gmbh
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
